Journal of Antimicrobial Chemotherapy (1999) 43, 273-276
© 1999 The British Society for Antimicrobial Chemotherapy
Brief reports |
Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK
Division of Microbiology and PHLS Laboratory, University Hospital, Queen':s Medical Centre, Nottingham NG7 2UH, UK
The carbapenemase gene (cfiA) was detected in 12 (6.9%) out of 175 clinical isolates of Bacteroides fragilis from Nottingham, three times the frequency reported from France. Only one gene copy was present in all cases. Eleven (6.3%) of the cfiA-positive isolates were susceptible to imipenem or meropenem (MIC < 8 mg/L); strains of this type have the potential to convert to high-level resistance. One isolate (0.6%) displayed resistance to both carbapenem antibiotics and was associated with specific carbapenemase activity six times that of the sensitive isolates.
* Tel: +44-115-9249924, ext. 42632; Fax: +44-115-9709233; E-mail: richard.edwards{at}nottingham.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. L. Buckwold, N. B. Shoemaker, C. L. Sears, and A. A. Franco Identification and Characterization of Conjugative Transposons CTn86 and CTn9343 in Bacteroides fragilis Strains Appl. Envir. Microbiol., January 1, 2007; 73(1): 53 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Rodloff, E. J. C. Goldstein, and A. Torres Two decades of imipenem therapy J. Antimicrob. Chemother., November 1, 2006; 58(5): 916 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gal and J. S. Brazier Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants J. Antimicrob. Chemother., July 1, 2004; 54(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Soki, E. Fodor, D. W. Hecht, R. Edwards, V. O. Rotimi, I. Kerekes, E. Urban, and E. Nagy Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait J. Med. Microbiol., May 1, 2004; 53(5): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Piriz, S. Vadillo, A. Quesada, J. Criado, R. Cerrato, and J. Ayala Relationship between penicillin-binding protein patterns and {beta}-lactamases in clinical isolates of Bacteroides fragilis with different susceptibility to {beta}-lactam antibiotics J. Med. Microbiol., March 1, 2004; 53(3): 213 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Hecht and J. R. Osmolski Activities of Garenoxacin (BMS-284756) and Other Agents against Anaerobic Clinical Isolates Antimicrob. Agents Chemother., March 1, 2003; 47(3): 910 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Edwards and P. N. Read Expression of the carbapenemase gene (cfiA) in Bacteroides fragilis J. Antimicrob. Chemother., December 1, 2000; 46(6): 1009 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. SOKI, E. URBAN, I. SZOKE, E. FODOR, and E. NAGY Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary J. Med. Microbiol., May 1, 2000; 49(5): 427 - 430. [Abstract] [Full Text] [PDF] |
||||



